Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Summer Epiphany: Carpe Sanctum

"Destroyers seize gold and leave to its owners a counterfeit pile of paper." – Ayn Rand Twelve days ago, we were forced by gale force winds to seek safe harbor in the lovely northern Ontario town of Britt, located on the north shore of the Magnetawan River, approximat...
Streetwise Reports | August 22, 2019 |

Global Insanity Prevails

"Destroyers seize gold and leave to its owners a counterfeit pile of paper." —Ayn Rand Why don't we start things off a tad differently this evening? Let me relate to you all a parable from the Book of Quantitative Easing where all is good and noble in the world of gov...
Streetwise Reports | September 16, 2019 |

Emerging opportunity in a growing, high-value dermatological market

The following is a transcription of the above video, and The Market Online has edited it for clarity . Kane Biotech Inc. (TSXV:KNE) , a Canadian-based biotech company engaged in the development and commercialization of products that prevent and remove microbial biof...
Ryan Dhillon | April 11, 2024 |

Buzz on the Bullboards: Which stocks shook off the “Blue Mondays”?

Stock markets are off to the races for 2023, with the TSX logging a win streak of nine positive closes before ending in the red, while the Dow also recently snapped a four-day win streak after Goldman Sachs posted its biggest earnings whiff in more than 10 years and execu...
Jonathon Brown | January 19, 2023 |

Meet the plant-based food company that’s set for success

Welcome to the Market Herald Video Q&A Podcast. I’m Brieanna McCutcheon. Most people, if not everyone, know someone vegan, vegetarian, or flexitarian. This is good news for companies like Naturally Splendid, which aim to provide tasty and delicious...
Brieanna McCutcheon | September 23, 2022 |

Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19

Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil. Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW:FSE) , a Canada-based clinical stage drug development company that focuses on drug repurposing, believes ...
Streetwise Reports | May 28, 2020 |

Coverage Initiated on Maker of Antibiotic-Free Supplement for Livestock Feed

The highlights of this investment story are outlined in a Zacks Small-Cap Research report. In a Nov. 19 research note, analyst David Bautz reported that Zacks Small-Cap Research initiated coverage on Avivagen Inc. (VIV:TSX.V; CHEXF:OTCMKTS) with a US$2.50 valuation....
Streetwise Reports | November 27, 2019 |

AIM ImmunoTech Shares Soar as Japan's NIID Tests Ampligen® as Potential Coronavirus Treatment

Shares of AIM ImmunoTech traded more than 150% higher after the company reported that Japan's National Institute of Infectious Diseases will test its Ampligen® drug as a potential treatment for the coronavirus. Immuno-pharmaceutical company AIM Imm...
Streetwise Reports | March 10, 2020 |

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May

Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expec...
Streetwise Reports | April 9, 2020 |

Your One-stop-shop for All Things Plant-based is This Company

(Click image to play video) It’s no secret that the alternative meat and plant-based sector has gone through tremendous growth over the last several years as people shift away from animal-based products. Similarly, companies are also cap...
Jocelyn Aspa | May 4, 2021 |
1 2 3 4 5 6 7